Medicare Enrolled

Dr. Roberto Lopez-Alberola

Neurology with Special Qualifications in Child Neurology Physician · Miami, FL
Speaking/Promotional
1475 NW 12TH AVE, Miami, FL 33136
3052437520
In practice since 2006 (19 years)
NPI: 1417977554 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lopez-Alberola from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lopez-Alberola? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lopez-Alberola

Dr. Roberto Lopez-Alberola is a neurology with special qualifications in child neurology physician in Miami, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Lopez-Alberola received a total of $22,556 from 27 pharmaceutical and/or device companies across 117 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology with special qualifications in child neurology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lopez-Alberola is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $22,556 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$22,556
Total received (2018-2024)
Avg $3,222/year across 7 years
Top 15% in FL for neurology with special qualifications in child neurology physician
27
Companies
117
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,159 (40.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,607 (38.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,790 (21.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,185
2023
$3,274
2022
$963
2021
$8,354
2020
$5,257
2019
$1,795
2018
$728

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$8,092
Biogen, Inc.
$5,059
LivaNova USA, Inc.
$4,664
Sarepta Therapeutics, Inc.
$1,099
Vertex Pharmaceuticals Incorporated
$575
UCB, Inc.
$400
AstraZeneca Pharmaceuticals LP
$351
PTC Therapeutics, Inc.
$326
JAZZ PHARMACEUTICALS INC.
$296
Novo Nordisk Inc
$248
Neurelis, Inc.
$241
Genentech USA, Inc.
$210
Medtronic, Inc.
$171
Baudax Bio Inc.
$124
Allergan, Inc.
$123
Novartis Pharmaceuticals Corporation
$122
NS Pharma, Inc.
$110
BioMarin Pharmaceutical Inc.
$74
ABBVIE INC.
$63
EAGLE PHARMACEUTICALS, INC.
$44
PFIZER INC.
$36
GENZYME CORPORATION
$31
ACADIA Pharmaceuticals Inc
$21
ITF Therapeutics LLC
$19
Sunovion Pharmaceuticals Inc.
$19
SANOFI PASTEUR INC.
$19
Greenwich Biosciences, Inc.
$18
Top 3 companies account for 79.0% of total payments
Associated products mentioned in payments ›
ANJESO · APTIOM · ARCTIC FRONT ADVANCE · BARHEMSYS · BOTOX · Brineura · Briviact · DAYBUE · EPIDIOLEX · Elevidys · Emflaza · Epidiolex · Evrysdi · Exondys 51 · FARXIGA · FLUZONE HIGH-DOSE · GILENYA · Ozempic · RYBELSUS · SPINRAZA · VALTOCO · VILTEPSO · VNS Therapy · Vimpat · ZOLGENSMA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (41%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology with special qualifications in child neurology physician and does not inherently indicate bias, but patients may wish to be aware.

Looking for a neurology with special qualifications in child neurology physician in Miami?
Compare neurology with special qualifications in child neurology physicians in the Miami area by procedure volume, costs, and industry payment transparency.
Browse neurology with special qualifications in child neurology physicians nearby

Geographic Context

Neurology with Special Qualifications in Child Neurology Physicians within 10 mi
28
Per 100K population
1.0
County median income
$68,694
Nearest hospital
JACKSON HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lopez-Alberola is a neurology with special qualifications in child neurology physician, and high industry engagement (speaking/promotional, top 15%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Lopez-Alberola receive payments from pharmaceutical companies?
Yes. Dr. Lopez-Alberola received a total of $22,556 from 27 companies across 117 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Lopez-Alberola) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Neurology with Special Qualifications in Child Neurology Physicians in Miami
Browse neurology with special qualifications in child neurology physicians in Miami ranked by procedure volume and transparency data.
Highest volume
Top Neurology with Special Qualifications in Child Neurology Physicians in FL
Neurology with Special Qualifications in Child Neurology Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurology with Special Qualifications in Child Neurology Physicians in FL
Which FL neurology with special qualifications in child neurology physicians receive the most from drug and device companies.
By company
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) Payments to Doctors
See all physicians who received payments from Novartis Gene Therapies, Inc. (fka AveXis, Inc.).
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc..
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →